BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15323185)

  • 1. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Maillard reaction inhibitors and their biological and therapeutic significance.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):156-8. PubMed ID: 15323184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
    Chellan P; Nagaraj RH
    Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoxidation: the menace of diabetes and aging.
    Vlassara H; Palace MR
    Mt Sinai J Med; 2003 Sep; 70(4):232-41. PubMed ID: 12968196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
    Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
    Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maillard reaction products in tissue proteins: new products and new perspectives.
    Thorpe SR; Baynes JW
    Amino Acids; 2003 Dec; 25(3-4):275-81. PubMed ID: 14661090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and amino acid glycation: new insights into the Maillard reaction.
    Horvat S; Jakas A
    J Pept Sci; 2004 Mar; 10(3):119-37. PubMed ID: 15113085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The maillard reaction in eye diseases.
    Stitt AW
    Ann N Y Acad Sci; 2005 Jun; 1043():582-97. PubMed ID: 16037281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein glycation: creation of catalytic sites for free radical generation.
    Yim MB; Yim HS; Lee C; Kang SO; Chock PB
    Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation endproducts and cigarette smoking.
    Nicholl ID; Bucala R
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products overload might explain intracellular cobalamin deficiency in renal dysfunction, diabetes and aging.
    Obeid R; Shannan B; Herrmann W
    Med Hypotheses; 2011 Nov; 77(5):884-8. PubMed ID: 21880434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Maillard reaction in the human body. The main discoveries and factors that affect glycation.
    Tessier FJ
    Pathol Biol (Paris); 2010 Jun; 58(3):214-9. PubMed ID: 19896783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Amadori product on protein: structure and reactions.
    Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
    Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
    Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
    Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of reactive intermediates from Amadori compounds under physiological conditions.
    Zyzak DV; Richardson JM; Thorpe SR; Baynes JW
    Arch Biochem Biophys; 1995 Jan; 316(1):547-54. PubMed ID: 7840665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advanced glycation end products or Maillard products].
    Wautier JL
    Rev Prat; 1998 Nov; 48(17):1865-7. PubMed ID: 9854387
    [No Abstract]   [Full Text] [Related]  

  • 19. Age-related changes in the glycation of human aortic elastin.
    Konova E; Baydanoff S; Atanasova M; Velkova A
    Exp Gerontol; 2004 Feb; 39(2):249-54. PubMed ID: 15036419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.